| mRNA |
AM-580 |
CTRPv2 |
pan-cancer |
AAC |
0.0065 |
0.9 |
| mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.0065 |
0.9 |
| mRNA |
OSI-027 |
GDSC1000 |
pan-cancer |
AAC |
-0.0053 |
0.9 |
| mRNA |
BRD-K51831558 |
CTRPv2 |
pan-cancer |
AAC |
-0.0092 |
0.9 |
| mRNA |
HG-5-113-01 |
GDSC1000 |
pan-cancer |
AAC |
0.008 |
0.9 |
| mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0064 |
0.9 |
| mRNA |
RO-3306 |
GDSC1000 |
pan-cancer |
AAC |
0.0059 |
0.9 |
| mRNA |
BRD-K42260513 |
CTRPv2 |
pan-cancer |
AAC |
0.0097 |
0.9 |
| mRNA |
PFI-1 |
GDSC1000 |
pan-cancer |
AAC |
-0.0054 |
0.9 |
| mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0062 |
0.9 |